on January 31, 2008
Published online before print January 31, 2008, doi: 10.1161/STROKEAHA.107.495499
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 19, 2007
From the Departments of Hematology (E.Y.L.C., F.W.G.L., M.P.M.M.), and Neurology (D.W.J.D.), Erasmus University Medical Center, Rotterdam; and The Haemostasis and Thrombosis Research Center (S.U.W., H.L.V., R.M.B), Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands. * To whom correspondence should be addressed. E-mail: m.demaat{at}erasmusmc.nl.
Background and Purpose—To determine the contribution of fibrinogen Methods—Associations between fibrinogen Results—Fibrinogen Conclusions—Fibrinogen
Revised on July 18, 2007
Accepted on August 14, 2007
Fibrinogen
Elim Y.L. Cheung MSc; 
’ in Ischemic Stroke. A Case-Control Study
’ levels and FGG haplotypes to ischemic stroke.’ levels, fibrinogen ’/total fibrinogen ratio, and FGG haplotypes with the risk of ischemic stroke were determined in 124 cases and 125 controls.’/total fibrinogen ratio was higher in patients than in controls during the acute phase of the stroke and lower in the convalescent phase 3 months after the stroke. FGG haplotype 3 (H3) was associated with a reduced risk of ischemic stroke (odds ratio 0.60; 95% CI, 0.38 to 0.94), but not with the fibrinogen ’/total fibrinogen ratio. In contrast, FGG-H2 was associated with a decreased fibrinogen ’/total fibrinogen ratio, but not with risk of stroke.’/total fibrinogen ratio is associated with ischemic stroke, especially in the acute phase of the disease. In addition, FGG-H3 haplotype appears to be protective against ischemic stroke.
Key words: FGG haplotypes • fibrinogen
’/total fibrinogen ratios •
ischemic stroke